Example: Heart Attack

Search clinical trials for: Excitatory Amino Acid Agents

Total 1571 results

    • NCT02511873
      Unknown status
      Fycompa in Subjects With Small Fiber Neuropathy (SFN)
      Conditions: Neuropathy, Small Fiber
    • NCT04032301
      Recruiting
      Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
      Conditions: Post-Traumatic Stress Disorders; Major Depressive Disorder
    • NCT02577250
      Completed
      Ketamine Infusions for PTSD and Treatment-Resistant Depression
      Conditions: Depressive Disorder, Treatment-Resistant; Stress Disorders, Post-Traumatic
    • NCT02340325
      Completed
      FS2 Safety and Tolerability Study in Healthy Volunteers
      Conditions: Cicatrix; Cicatrix, Hypertrophic; Keloid
    • NCT01546051
      Completed
      A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers
      Conditions: Healthy
    • NCT01722578
      Completed
      L-ornithine L-aspartate in Overt Hepatic Encephalopathy
      Conditions: Cirrhosis of Liver; Hepatic Encephalopathy
    • NCT02373124
      Completed
      Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial
      Conditions: Cocaine Use Disorders
    • NCT02950233
      Terminated
      Preventing pAIn With NMDA Antagonists - Steroids in Thoracoscopic lObectomy Procedures (PAIN-STOP) Pilot Trial
      Conditions: Pain, Postoperative
    • NCT01440829
      Completed
      The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
      Conditions: Decompensated Cirrhosis; Portal Hypertension; Bleeding Varices; Refractory Ascites
    • NCT01548703
      Completed
      A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers
      Conditions: Healthy
    • NCT01041755
      Completed
      Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
      Conditions: Hepatic Encephalopathy
    • NCT00896831
      Unknown status
      Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
      Conditions: Hepatic Encephalopathy
    • NCT00785811
      Terminated
      Effect of Chronic Supplementation of L-arginine in the Muscular Performance
      Conditions: Muscular Fatigue
    • NCT00696332
      Completed
      Talampanel for Amyotrophic Lateral Sclerosis (ALS)
      Conditions: ALS
    • NCT00470314
      Unknown status
      Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure
      Conditions: Acute Liver Failure
    • NCT00433368
      Completed
      Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
      Conditions: Hepatic Encephalopathy
    • NCT00305591
      Completed
      Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.
      Conditions: Cirrhosis; Hepatic Encephalopathy
    • NCT02523703
      Completed
      Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study
      Conditions: Multiple Sclerosis
    • NCT00142233
      Completed
      EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis
      Conditions: Pancreatitis
    • NCT02634684
      Completed
      Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.
      Conditions: Schizophrenia
    • NCT00740142
      Completed
      Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy
      Conditions: Hepatic Encephalopathy
    • NCT04278404
      Recruiting
      Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
      Conditions: Coronavirus Infection (COVID-19); Pulmonary Arterial Hypertension; Urinary Tract Infections in Children; Hypertension; Pain; Hyperphosphatemia; Primary Hyperaldosteronism; Edema; Hypokalemia; Heart Failure; Hemophilia; Menorrhagia; Insomnia; Pneumonia; Skin Infection; Arrythmia; Asthma in Children; Bronchopulmonary Dysplasia; Adrenal Insufficiency; Fibrinolysis; Hemorrhage; Attention Deficit Hyperactivity Disorder; Multisystem Inflammatory Syndrome in Children (MIS-C); Kawasaki Disease; Coagulation Disorder; Down Syndrome
    • NCT00034229
      Completed
      Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression
      Conditions: Bipolar Disorder
    • NCT03962725
      Suspended
      Avoiding Neuromuscular Blockers to Reduce Complications
      Conditions: Respiratory Failure; Respiratory Infection; Aspiration Pneumonia; Pneumonitis; Atelectasis; Bronchospasm
    • NCT04117178
      Recruiting
      Monitoring Anti-Dementia Drugs by Serum Levels
      Conditions: Dementia; Dementia With Lewy Bodies; Dementia in Parkinsons Disease; Dementia Alzheimers; Alzheimer Disease
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations